Ubiquitination in rheumatoid arthritis.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
15 Nov 2020
Historique:
received: 14 07 2020
revised: 08 09 2020
accepted: 14 09 2020
pubmed: 23 9 2020
medline: 20 11 2020
entrez: 22 9 2020
Statut: ppublish

Résumé

Rheumatoid arthritis is a chronic, inflammatory joint disease leading to inflammation of synovial membrane that lines the joints. This inflammation further progresses and results in destruction of joints and surrounding cartilages. The underlying factors can be oxidative stress, pro-inflammatory mediators, imbalance and attenuation between various enzymes and proteins (like nuclear factor erythroid 2 related factor 2/Nrf2 and ubiquitin). Protein degradation pathways comprises of lysosomal, proteasomal pathway, and autophagosome (that are carried out in mammalian cells) are regulated through ubiquitin. Ubiquitin proteasomal system is dominating pathway for carrying out non-lysosomal proteolysis of intracellularly proteins. Fundamental processes including cell cycle progression, process of division, apoptosis, modulation of immune responses and cell trafficking are regulated by process of ubiquitination. Ubiquitin proteasomal pathway (UPP) includes ubiquitin moieties which are covalently attached to proteins and guides them proteasome for degradation. Misfolded, oxidized and damaged proteins which are responsible for critical processes, are major targets of degradation process. Any alteration in this system leads to dysregulated cellular homeostasis; progressively leading to numerous diseases including rheumatoid arthritis. Factors including TAK1, TRAF6 undergo are required for the progression of disease and thus contributes towards pathology of inflammatory disorders such as rheumatoid arthritis. This review will include all linked aspects which contribute its major role in rheumatoid arthritis.

Identifiants

pubmed: 32961230
pii: S0024-3205(20)31212-1
doi: 10.1016/j.lfs.2020.118459
pii:
doi:

Substances chimiques

Ubiquitin 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

118459

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Tapan Behl (T)

Chitkara College of Pharmacy, Chitkara University, Punjab, India. Electronic address: tapanbehl31@gmail.com.

Swati Chadha (S)

Chitkara College of Pharmacy, Chitkara University, Punjab, India.

Monika Sachdeva (M)

Fatima College of Health Sciences, Al Ain, United Arab Emirates.

Arun Kumar (A)

Chitkara College of Pharmacy, Chitkara University, Punjab, India.

Abdul Hafeez (A)

Glocal School of Pharmacy, Glocal University, Mirzapur Pole, Uttar Pradesh, India.

Vineet Mehta (V)

Department of Pharmacology, Government College of Pharmacy, Rohru, Ditt. Shimla, Himachal Pradesh, India.

Simona Bungau (S)

Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH